Catalent Stock Today

CTLT Stock  USD 57.98  0.16  0.28%   


19 of 100


Odds Of Distress

Less than 25

Catalent is selling for under 57.98 as of the 20th of February 2024; that is -0.28 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 57.67. Catalent has about a 25 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat solid performance during the last 90 days. Equity ratings for Catalent are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 21st of January 2024 and ending today, the 20th of February 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
31st of July 2014
Health Care
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The company was incorporated in 2007 and is headquartered in Somerset, New Jersey. The company has 180.74 M outstanding shares of which 11.13 M shares are currently shorted by private and institutional investors with about 6.12 trading days to cover. More on Catalent

Moving together with Catalent Stock

  0.76EQ Equillium Buyout TrendPairCorr

Moving against Catalent Stock

  0.91VALN Valneva SE ADR Report 28th of March 2024 PairCorr
  0.89MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.79YS YS Biopharma Report 22nd of April 2024 PairCorr
  0.78KA Kineta Inc Report 29th of March 2024 PairCorr
  0.68VAXX Vaxxinity Report 25th of March 2024 PairCorr
  0.57MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.41DNLI Denali Therapeutics Earnings Call This WeekPairCorr

Catalent Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Catalent's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Catalent or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ChairmanJohn Chiminski
Thematic IdeaObamacare Repeal (View all Themes)
SEC FilingsCatalent Security & Exchange Commission EDGAR Reports
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, SP 500 Index, ARCA Pharmaceutical, Obamacare Repeal, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering Catalent report their recommendations after researching Catalent's financial statements, talking to executives and customers, or listening in on Catalent's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Catalent. The Catalent consensus assessment is calculated by taking the average forecast from all of the analysts covering Catalent.
Financial Strength
Based on the key indicators related to Catalent's liquidity, profitability, solvency, and operating efficiency, Catalent is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March. Financial strength of Catalent is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Shares Diluted138.7 M162.9 M
Fairly Down
Slightly volatile
Weighted Shares191.9 M207.3 M
Significantly Down
Slightly volatile
Return on Assets(0.0283)(0.0276)
Fairly Down
Very volatile
Net Cash Flow from Operations318.5 M292.1 M
Significantly Up
Slightly volatile
Current Liabilities1.9 B1.8 B
Significantly Up
Slightly volatile
Total LiabilitiesB7.1 B
Fairly Down
Slightly volatile
Gross Margin0.250.22
Moderately Up
Slightly volatile
Total Debt4.6 B5.6 B
Significantly Down
Slightly volatile
Asset Turnover0.420.36
Fairly Up
Slightly volatile
Current Assets2.5 B3.1 B
Significantly Down
Slightly volatile
Total Assets9.9 B12.4 B
Significantly Down
Slightly volatile
Catalent's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Catalent's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Catalent's financial leverage. It provides some insight into what part of Catalent's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Catalent's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Catalent deploys its capital and how much of that capital is borrowed.
Catalent cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 4.85 B in liabilities with Debt to Equity (D/E) ratio of 0.9, which is about average as compared to similar companies. Catalent has a current ratio of 2.8, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Catalent until it has trouble settling it off, either with new capital or with free cash flow. So, Catalent's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Catalent sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Catalent to invest in growth at high rates of return. When we think about Catalent's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

318.53 Million
Catalent (CTLT) is traded on New York Stock Exchange in USA. It is located in 14 Schoolhouse Road, Somerset, NJ, United States, 08873 and employs 18,000 people. Catalent is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 10.51 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Catalent's market, we take the total number of its shares issued and multiply it by Catalent's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Catalent conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 180.74 M outstanding shares of which 11.13 M shares are currently shorted by private and institutional investors with about 6.12 trading days to cover. Catalent currently holds about 345 M in cash with 261 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.92.
Check Catalent Probability Of Bankruptcy
Ownership Allocation
Catalent retains a total of 180.74 Million outstanding shares. The majority of Catalent outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Catalent to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Catalent. Please pay attention to any change in the institutional holdings of Catalent as this could imply that something significant has changed or about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Catalent Ownership Details

Catalent Stock Price Odds Analysis

Attributed to a normal probability distribution, the odds of Catalent jumping above the current price in 90 days from now is nearly 4.27%. The Catalent probability density function shows the probability of Catalent stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.8684 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Catalent will likely underperform. Additionally, the company has an alpha of 0.5579, implying that it can generate a 0.56 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 57.98HorizonTargetOdds Above 57.98
95.71%90 days
Based on a normal probability distribution, the odds of Catalent to move above the current price in 90 days from now is nearly 4.27 (This Catalent probability density function shows the probability of Catalent Stock to fall within a particular range of prices over 90 days) .

Catalent Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Catalent that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Catalent's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Catalent's value.
InstituionRecorded OnShares
Nomura Holdings Inc2023-09-30
4.3 M
Elliott Investment Management L.p.2023-09-30
Geode Capital Management, Llc2023-09-30
Ameriprise Financial Inc2023-09-30
3.5 M
Capital Research & Mgmt Co - Division 32023-12-31
Amvescap Plc.2023-09-30
2.8 M
Norges Bank2023-12-31
2.6 M
Morgan Stanley - Brokerage Accounts2023-09-30
2.2 M
Northern Trust Corp2023-09-30
2.2 M
Vanguard Group Inc2023-09-30
20.5 M
Capital World Investors2023-12-31
19.1 M
View Catalent Diagnostics

Catalent Historical Income Statement

Catalent Income Statement is one of the three primary financial statements used for reporting Catalent's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Catalent revenue and expense. Catalent Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Catalent's Direct Expenses is comparatively stable as compared to the past year. Operating Expenses is likely to gain to about 1.5 B in 2024, whereas Earning Before Interest and Taxes EBIT is likely to drop (184.1 M) in 2024. View More Fundamentals

Catalent Stock Against Markets

Picking the right benchmark for Catalent stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Catalent stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Catalent is critical whether you are bullish or bearish towards Catalent at a given time. Please also check how Catalent's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Catalent without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Companies Directory Now


Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Catalent Corporate Directors

Catalent corporate directors refer to members of a Catalent board of directors. The board of directors generally takes responsibility for the Catalent's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Catalent's board members must vote for the resolution. The Catalent board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Bruce McEvoyDirectorProfile
James QuellaDirectorProfile
Gregory LucierIndependent DirectorProfile
Rolf ClassonIndependent DirectorProfile

How to buy Catalent Stock?

Before investing in Catalent, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Catalent. To buy Catalent stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Catalent. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Catalent stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Catalent stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Catalent stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Catalent, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Catalent Stock please use our How to Invest in Catalent guide.

Already Invested in Catalent?

The danger of trading Catalent is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Catalent is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Catalent. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Catalent is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Catalent is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Catalent Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Catalent Stock. Highlighted below are key reports to facilitate an investment decision about Catalent Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Catalent. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Catalent Stock please use our How to Invest in Catalent guide.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Catalent Stock analysis

When running Catalent's price analysis, check to measure Catalent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalent is operating at the current time. Most of Catalent's value examination focuses on studying past and present price action to predict the probability of Catalent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalent's price. Additionally, you may evaluate how the addition of Catalent to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Stocks Directory
Find actively traded stocks across global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Is Catalent's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Catalent. If investors know Catalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Catalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
The market value of Catalent is measured differently than its book value, which is the value of Catalent that is recorded on the company's balance sheet. Investors also form their own opinion of Catalent's value that differs from its market value or its book value, called intrinsic value, which is Catalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catalent's market value can be influenced by many factors that don't directly affect Catalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Catalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Catalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Catalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.